CR8286A - Derivados de piperazina inhibidores de quimioquinas y su uso para tratar miocarditis - Google Patents

Derivados de piperazina inhibidores de quimioquinas y su uso para tratar miocarditis

Info

Publication number
CR8286A
CR8286A CR8286A CR8286A CR8286A CR 8286 A CR8286 A CR 8286A CR 8286 A CR8286 A CR 8286A CR 8286 A CR8286 A CR 8286A CR 8286 A CR8286 A CR 8286A
Authority
CR
Costa Rica
Prior art keywords
chemiokin
inhibiting
piperazine derivatives
treat myocarditis
myocarditis
Prior art date
Application number
CR8286A
Other languages
English (en)
Inventor
Futamatsu Hideki
Isobe Mitsuaki
Koga Noritaka
Suzuki Jun-Ichi
William P Dole
Original Assignee
Schering Ag
Tokio Medical And Dental University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34216121&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR8286(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag, Tokio Medical And Dental University filed Critical Schering Ag
Publication of CR8286A publication Critical patent/CR8286A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se refiere al uso de derivados de piperazina para tratar la miocarditis.
CR8286A 2003-08-22 2006-03-14 Derivados de piperazina inhibidores de quimioquinas y su uso para tratar miocarditis CR8286A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49738003P 2003-08-22 2003-08-22

Publications (1)

Publication Number Publication Date
CR8286A true CR8286A (es) 2006-12-07

Family

ID=34216121

Family Applications (1)

Application Number Title Priority Date Filing Date
CR8286A CR8286A (es) 2003-08-22 2006-03-14 Derivados de piperazina inhibidores de quimioquinas y su uso para tratar miocarditis

Country Status (17)

Country Link
US (2) US20050043318A1 (es)
EP (1) EP1660089A1 (es)
JP (1) JP2007503397A (es)
CN (1) CN1838957A (es)
AR (1) AR046329A1 (es)
AU (1) AU2004266153A1 (es)
BR (1) BRPI0413846A (es)
CA (1) CA2534941A1 (es)
CR (1) CR8286A (es)
EC (1) ECSP066440A (es)
IL (1) IL173584A0 (es)
MX (1) MXPA06002053A (es)
NO (1) NO20061287L (es)
PE (1) PE20050871A1 (es)
RU (1) RU2006108865A (es)
WO (1) WO2005018642A1 (es)
ZA (1) ZA200602306B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2578529A1 (en) * 2004-08-18 2006-02-23 Ace Aps Cosmetic and pharmaceutical compositions comprising ace inhibitors and/or angiotensin ii receptor antagonists
US8097610B2 (en) 2005-08-26 2012-01-17 Shionogi & Co., Ltd. Derivative having PPAR agonistic activity
AU2014291711B2 (en) 2013-07-18 2017-02-02 Novartis Ag Autotaxin inhibitors comprising a heteroaromatic ring-benzyl-amide-cycle core

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59409631D1 (de) * 1993-07-15 2001-02-15 Hoffmann La Roche Pharmazeutische Kombination, die einen Hemmer des Renin-Angiotensin-Systems und einen Endothelin-Antagonisten enthält
US5631245A (en) * 1995-06-06 1997-05-20 Biodynamics Pharmaceuticals, Inc. Method for medicating the inflammatory controlling system and adverse inflammatory reactions and for making compounds for treating the pathology of adverse inflammatory reactions
US6207665B1 (en) * 1997-06-12 2001-03-27 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
US20020052420A1 (en) * 1998-12-02 2002-05-02 George Hasko Method and composition for modulating an immune response
AU4796700A (en) * 1999-05-13 2000-12-05 Dupont Pharmaceuticals Research Laboratories, Inc. Ureido-substituted cyclic amine derivatives and their use as drug
US7125895B1 (en) * 1999-05-14 2006-10-24 Bristol-Myers Squibb Pharma Research Labs, Inc. Cyclic amine derivatives and their uses
JP2001064202A (ja) * 1999-08-25 2001-03-13 Kissei Pharmaceut Co Ltd 心不全予防治療剤
US6740636B2 (en) * 2000-07-31 2004-05-25 Schering Aktiengesellschaft Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection

Also Published As

Publication number Publication date
CN1838957A (zh) 2006-09-27
ZA200602306B (en) 2009-08-26
NO20061287L (no) 2006-05-18
US20080269247A1 (en) 2008-10-30
ECSP066440A (es) 2006-09-18
BRPI0413846A (pt) 2006-10-24
JP2007503397A (ja) 2007-02-22
AU2004266153A1 (en) 2005-03-03
PE20050871A1 (es) 2005-11-02
WO2005018642A1 (en) 2005-03-03
EP1660089A1 (en) 2006-05-31
US20050043318A1 (en) 2005-02-24
RU2006108865A (ru) 2007-09-27
AR046329A1 (es) 2005-12-07
CA2534941A1 (en) 2005-03-03
IL173584A0 (en) 2006-07-05
MXPA06002053A (es) 2006-08-11

Similar Documents

Publication Publication Date Title
CU20070160A7 (es) Pirrolopirazoles, inhibidores potentes de quinasa
BRPI0412404A (pt) uso de rapamicina e de derivado da rapamicina para o tratamento da perda óssea
GT200600035A (es) Aminopiridinas como inhibidores de beta-secretasa
CR8451A (es) Uso de derivados de n-arilhidracina para combatir pestes
ECSP088558A (es) Carbonilamino pirrolopirazoles, potentes inhibidores de quinasa
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2
ECSP066467A (es) Formas Polimórficas de 3-(4-amino-1-Oxo-1-3 DIhidroisoindol-2-IL)-Piperidin-2,6-Diona
HN2003000285A (es) Nuevas quinazolinonas espirocondensadas y su uso como inhibidores de la fosfodiesterasa
MXPA03001511A (es) Imidazol-5-il-2-amino-pirimidinas como agentes para la inhibicion de la proliferacion celular.
CR8559A (es) Pirazolopirimidinas
NO20081636L (no) FAP - inhibitorer
ATE471324T1 (de) Triazolophthalazine
DE60106954D1 (de) Resorcin-derivate
EA200701707A1 (ru) Пиразолопиримидины
PA8618901A1 (es) Biaril sulfonamidas y metodo para el uso de las mismas
PA8575601A1 (es) Procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso
CR8135A (es) Triazolopirimidinas
TR201901390T4 (tr) Demodikoza karşı madde.
CL2004001678A1 (es) Compuestos derivados de oxazolidinona; composicion farmaceutica; y uso de los compuestos como agentes bacterianos.
UY29109A1 (es) Derivados de alquiliden-tetrahidronaftaleno, procedimiento para su preparacion y su uso como antiinflamatorios
UY27203A1 (es) Bencimidazoles útiles en el tratamiento de la disfunción sexual
MY146803A (en) Benzothiazol-2-on derivatives as lipase and phospholipase inhibitors
CR8286A (es) Derivados de piperazina inhibidores de quimioquinas y su uso para tratar miocarditis
CR8443A (es) Pirazolopirimidinas
EA200600601A1 (ru) Производные аминопиридина в качестве ингибиторов индуцируемой no-синтазы